BRIEF published on 01/06/2025 at 17:35, 1 year 10 months ago EUROPLASMA: Details on Capital and Voting Rights as of December 31, 2024 Voting Rights Capital Euronext Europlasma 2024
PRESS RELEASE published on 01/06/2025 at 17:30, 1 year 10 months ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 décembre 2024 EUROPLASMA déclare le nombre total de droits de vote et d'actions au 31 décembre 2024. Informations réglementaires conformes aux exigences légales Capital Droits De Vote Europlasma Réglementaire Nombre Total
BRIEF published on 12/11/2024 at 18:05, 1 year 10 months ago Europlasma obtient une licence d'exportation vers la République tchèque Europlasma Exportation Licence Forges De Tarbes République Tchèque
BRIEF published on 12/11/2024 at 18:05, 1 year 10 months ago Europlasma obtains export license to the Czech Republic Europlasma Czech Republic License Export Forges Of Tarbes
PRESS RELEASE published on 12/11/2024 at 18:00, 1 year 10 months ago EUROPLASMA: Obtention d’une nouvelle licence export vers la République tchèque Europlasma obtient une licence export vers la République tchèque pour l'exportation de corps creux de gros calibre, renforçant ses activités stratégiques en décarbonation et dépollution Europlasma Décarbonation Corps Creux Licence Export République Tchèque
BRIEF published on 12/05/2024 at 14:16, 1 year 11 months ago EUROPLASMA : Détails des Droits de Vote et Actions au 30 Novembre 2024 Droits De Vote Europlasma Euronext Growth Actions En Circulation 30 Novembre 2024
BRIEF published on 12/05/2024 at 14:16, 1 year 11 months ago EUROPLASMA: Details of Voting Rights and Shares as of November 30, 2024 Voting Rights Europlasma Euronext Growth Shares Outstanding November 30, 2024
BRIEF published on 12/05/2024 at 14:15, 1 year 11 months ago EUROPLASMA : Informations sur le capital et les droits de vote au 30 novembre 2024 Droits De Vote Capital Social Europlasma Euronext Growth Environnement
BRIEF published on 12/05/2024 at 14:15, 1 year 11 months ago EUROPLASMA: Information on capital and voting rights as of November 30, 2024 Share Capital Voting Rights Europlasma Euronext Growth Environment
PRESS RELEASE published on 12/05/2024 at 14:11, 1 year 11 months ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 30 novembre 2024 EUROPLASMA déclare le nombre total de droits de vote et d'actions au 30 novembre 2024. Détails sur son capital social et activités industrielles Droits De Vote Capital Social Europlasma Déchets Dangereux Décarbonation
Published on 11/06/2026 at 22:15, 2 days 11 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 09:30, 25 minutes ago Shelly Group: Invitation to Earnings Webcast/Call on 11 November 2026 on Unaudited 9M 2026 Results
Published on 11/09/2026 at 09:00, 55 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 55 minutes ago Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 55 minutes ago Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 55 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 07:00, 2 hours 55 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 55 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 55 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 55 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
